Who owns COGNITION THERAPEUTICS INC?
- Ticker: CGTX
- CUSIP Number: 19243b102
Tip: Access positions for across all investors
Analyze quarterly positions in Cognition Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Cognition Therapeutics stock
Who bought or sold COGNITION THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 1.9M | $3.5M | -7% | Mar 2024 |
|
| Vanguard Group | 922k | $1.7M | 28% | Mar 2024 |
|
| AWM Investment Company | 650k | $1.2M | 100% | Mar 2024 |
|
| Alyeska Investment Group | 500k | $910k | 100% | Mar 2024 |
|
| Timelo Investment Management | 481k | $875k | 100% | Mar 2024 |
|
| Corsair Capital Management | 285k | $519k | 100% | Mar 2024 |
|
| Hohimer Wealth Management | 225k | $410k | 100% | Mar 2024 |
|
| Kestra Advisory Services | 219k | $406k | 23% | Dec 2023 |
|
| American Financial Group | 205k | $373k | 0% | Mar 2024 |
|
| Geode Capital Management | 185k | $337k | 6% | Mar 2024 |
|
| CM Management | 175k | $319k | 100% | Mar 2024 |
|
| Sigma Planning | 159k | $290k | 458% | Mar 2024 |
|
| Commonwealth Equity Services | 93k | $169k | 0% | Mar 2024 |
|
| Bridgeway Capital Management | 77k | $140k | 16% | Mar 2024 |
|
| Mercer Global Advisors | 72k | $131k | -45% | Mar 2024 |
|
| BlackRock | 56k | $102k | -1% | Mar 2024 |
|
| Texas Capital Bank Wealth Management Services | 55k | $101k | 0% | Mar 2024 |
|
| Fca Corp | 52k | $94k | 0% | Mar 2024 |
|
| Northern Trust | 48k | $86k | 55% | Mar 2024 |
|
| Castle Wealth Management | 43k | $79k | 0% | Mar 2024 |
|
| Levin Capital Strategies | 30k | $55k | 100% | Mar 2024 |
|
| Tocqueville Asset Management | 26k | $47k | 100% | Mar 2024 |
|
| Northeast Financial Consultants | 25k | $45k | 0% | Mar 2024 |
|
| Bangor Savings Bank | 24k | $44k | 0% | Mar 2024 |
|
| HighTower Advisors | 23k | $41k | -30% | Mar 2024 |
|
| Baird Financial | 22k | $41k | 0% | Dec 2023 |
|
| Gratus Capital | 18k | $34k | 100% | Mar 2024 |
|
| Acadian Asset Management | 13k | $23k | 100% | Mar 2024 |
|
| Smith Anglin Financial | 12k | $22k | 0% | Mar 2024 |
|
| Charles Schwab Investment Management | 12k | $22k | 0% | Mar 2024 |
|
| Virtu Financial | 11k | $21k | 100% | Dec 2023 |
|
| Raymond James & Associates | 10k | $18k | 100% | Mar 2024 |
|
| Tower Research Capital | 6.4k | $12k | 80% | Mar 2024 |
|
| Northwestern Mutual Wealth Management Company | 5.9k | $11k | 0% | Mar 2024 |
|
| Bank of America Corporation | 5.0k | $9.1k | 0% | Mar 2024 |
|
| Morgan Stanley | 3.0k | $5.5k | -86% | Mar 2024 |
|
| Ariel Capital Advisors | 2.3k | $4.1k | 0% | Mar 2024 |
|
| Qube Research & Technologies | 2.1k | $3.9k | 100% | Mar 2024 |
|
| Sandy Spring Bank | 2.0k | $3.6k | 100% | Mar 2024 |
|
| Advisor Group Holdings | 1.2k | $2.1k | 100% | Mar 2024 |
|
| Wells Fargo & Company | 146.00 | $265.997400 | 7% | Mar 2024 |
|
| Jpmorgan Chase & Co | 70.00 | $127.001000 | 100% | Mar 2024 |
|
| Royal Bank of Canada | 4.00 | $0 | -98% | Mar 2024 |
|
| FMR | 1.00 | $2.000000 | 0% | Mar 2024 |
|
Who sold out of Cognition Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Pathstone Holdings | Dec 2023 | 2.2M | $4.1M |
| Worth Venture Partners | Dec 2023 | 509k | $941k |
| Voss Capital | Sep 2023 | 60k | $87k |
| Bank of New York Mellon | Dec 2023 | 18k | $33k |
| Rock Creek Group | Sep 2023 | 10k | $15k |
| Advisory Services Network | Dec 2023 | 2.5k | $4.6k |